Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration

J Rheumatol. 1997 May;24(5):912-5.

Abstract

Objective: To assess the frequency and clinical significance of amyloid deposits in abdominal fat in patients with ankylosing spondylitis (AS).

Methods: Abdominal subcutaneous fat aspiration (ASFA) by fine needle was performed in 137 unselected patients with AS of more than 5 years of disease evolution. A followup study was done of patients with amyloidosis in the abdominal fat (ASFA positive test) to evaluate the development of clinical amyloidosis.

Results: In 10 (9M/1F) patients with AS, the ASFA revealed amyloid deposits (prevalence of 7%). Patients with AS and an ASFA+ test were older and had more active and severe disease than those without AS. Only 2 ASFA positive test patients had clinical amyloidosis at the time of the test. After a followup period of 2-10 yrs (mean 5.4 +/- 3.2 yrs), 3 more patients developed symptomatology due to amyloidosis. All 5 patients with clinical amyloidosis showed nephropathy, and proteinuria was found in each. The remaining patients did not develop clinical amyloidosis during followup.

Conclusion: Amyloid deposits in abdominal fat are not a rare finding in AS. A significant proportion of these patients do not develop clinical amyloidosis after a followup of several years. Thus, an ASFA + test in patients with AS is not always associated with a poor prognosis at least in the short term, although longer followup is required.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / pathology*
  • Adult
  • Amyloidosis / drug therapy
  • Amyloidosis / epidemiology
  • Amyloidosis / etiology*
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Biopsy, Needle
  • Data Collection
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, IGA / complications
  • Glomerulonephritis, IGA / mortality
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Spondylitis, Ankylosing / complications*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal